drugset / Trial / NCT07644442
Study on [14C]HMPL-453（FGFR Inhibitor） in Healthy Chinese Adult Male Subjects
NaSingle-groupOpen-labelHealth-services research
Summary
To evaluate the absorption, metabolism and excretion in healthy Chinese male subjects after a single oral dose of \[14C\]HMPL-453
Timeline
- Start
- 2025-02-26
- Primary completion
- 2025-03-14
- Completion
- 2025-03-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HMPL-453 | Unknown | 300 mg | Oral |
Indications
No indication recorded.